Terry Carmack
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Radiopharmaceutical Chemistry and Applications
Papers in
-
- Radiopharmaceutical Chemistry and Applications 11
- Monoclonal and Polyclonal Antibodies Research 4
-
- Pharmacological Receptor Mechanisms and Effects 4
- Receptor Mechanisms and Signaling 3
- Co-authors
- Lisa Watkinson (23 shared papers)John R. Lever (9 shared papers)Charles J. Smith (8 shared papers)Kattesh V. Katti (5 shared papers)Silvia S. Jurisson (5 shared papers)Susan Z. Lever (4 shared papers)Cathy Cutler (5 shared papers)Evan Boote (2 shared papers)
- Journals
- Nuclear Medicine and Biology (8 papers)Nanomedicine Nanotechnology Biology and Medicine (1 paper)Journal of Nuclear Medicine (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Bioconjugate Chemistry (1 paper)
- Partner nations
- United StatesGreeceBrazil
In The Last Decade
Terry Carmack
24 papers receiving 524 citations
Peers
Comparison fields: 5 of 80
- Biomaterials 104
- Radiology, Nuclear Medicine and Imaging 157
- Biological Psychiatry 10
- Cellular and Molecular Neuroscience 65
- Radiation 30
Countries citing papers authored by Terry Carmack
This map shows the geographic impact of Terry Carmack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Carmack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Carmack more than expected).
Fields of papers citing papers by Terry Carmack
This network shows the impact of papers produced by Terry Carmack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Carmack. The network helps show where Terry Carmack may publish in the future.
Co-authors
The 25 scholars most cited alongside Terry Carmack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 200 | |
| 2 | 2017 | 76 | |
| 3 | 2017 | 38 | |
| 4 | 2009 | 35 | |
| 5 | 2014 | 27 | |
| 6 | 2013 | 26 | |
| 7 | 2015 | 26 | |
| 8 | 2016 | 19 | |
| 9 | 2021 | 18 | |
| 10 | 2011 | 15 | |
| 11 | 2018 | 12 | |
| 12 | Development of high specific activity 68Ga-labeled DOTA-rhenium cyclized alpha-MSH peptide analog to target MC1 receptors over-expressed by melanoma tumors | 2008 | 8 |
| 13 | 2024 | 8 | |
| 14 | 2019 | 5 | |
| 15 | 2022 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2025 | 3 | |
| 20 | Comparison of in vivo uptake of radioactive gold nanoparticles formulated using phytochemicals | 2015 | 2 |
About Terry Carmack
Terry Carmack is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Cellular and Molecular Neuroscience, having authored 25 papers that have together received 536 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (11 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Prostate Cancer Treatment and Research (4 papers), Peptidase Inhibition and Analysis (4 papers), Pharmacological Receptor Mechanisms and Effects (4 papers), Receptor Mechanisms and Signaling (3 papers), Neuropeptides and Animal Physiology (3 papers) and Mangiferin and Mango Extracts (2 papers). The work is most often cited by research in Biomaterials (104 citations), Radiology, Nuclear Medicine and Imaging (157 citations), Biological Psychiatry (10 citations), Cellular and Molecular Neuroscience (65 citations) and Radiation (30 citations). Terry Carmack has collaborated with scholars based in United States, Greece and Brazil. Frequent co-authors include Lisa Watkinson, John R. Lever, Charles J. Smith, Kattesh V. Katti, Silvia S. Jurisson, Susan Z. Lever, Cathy Cutler, Evan Boote, J. David Robertson and Dennis K. Miller. Their work appears in journals such as Nuclear Medicine and Biology, Nanomedicine Nanotechnology Biology and Medicine, Journal of Nuclear Medicine, Journal of Pharmacology and Experimental Therapeutics and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.